Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human beta cells against proinflammatory insults https://www.biorxiv.org/content/10.1101/2022.12.27.522037v1?med=mas
Deucravacitinib, a tyrosine kinase 2 pseudokinase inhibitor, protects human beta cells against proinflammatory insults https://www.biorxiv.org/content/10.1101/2022.12.27.522037v1?med=mas